Pharmaceutical Composition for prevention or treatment of diseases caused by SARS-CoV-2
KR20200076001A
Novel lactic acid bacteria capable of reducing body weight or body fat and use thereof
WO2019039778A1
Syringe
KR20190113169A
An ethanol extract composition of Citrus Unshiu Peel, Magnolia Bark, Corydalis and Gambir with improved skin wrinkles, moisturizing, antioxidant and anti-inflammatory effects
US2020039984A1
Novel [1,2,4]Triazolo[4,3-a]Quinoxaline Derivative, Method For Preparing Same, And Pharmaceutical Composition For Preventing Or Treating BET Protein-Related Diseases, Containing Same As Active Ingredient
US2020129440A1
Complex formulation comprising hmg-coa reductase inhibitor and clopidogrel
KR20190019489A
A composition for anti-cancer adjuvant comprising a RIP3 expression inducing agent or activator
AU2017251303A1
Pharmaceutical composition for preventing or treating respiratory disease comprising extract of Justicia procumbens L.
KR101849125B1
Solid Dispersions Comprising Proton Pump Inhibitor, Method for Preparing the Same and Orally Disintegrating Tablets Comprising the Same
KR20180022125A
Acid addition salts of diamine derivatives compound and preparation thereof
KR20170136771A
Proton pump inhibitor dispersion and pharmaceutical composition comprising the same
KR20170049895A
A method for manufacturing a sparkling fermented drink using Schisandra Fruit
KR20170036883A
A composition for preventing, treating and improving of voiding disorder comprising complex extracts
KR20160120503A
Chrono-system formulation for Celecoxib
EP3120859A1
Composition for preventing, treating, and alleviating urinary disturbances, containing piper longum l. extract
MX2016010177A
Antica.
KR20160044807A
Composition comprising extracts or fractions of Justicia genus
KR20150133433A
An Improved manufacturing method of Zabofloxacin
KR20150110949A
A composition for preventing, treating and improving of voiding disorder comprising herbal extract
KR20150103916A
1-Cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro[3,4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid D-aspartate hydrates and an antibacterial composition comprising their hydrates
